Literature DB >> 32416968

Effects of radiotherapy on olfaction and nasal function in head and neck cancer patients.

Preethi Rose Gurushekar1, Rajesh Isiah2, Subhashini John2, Tunny Sebastian3, Lalee Varghese4.   

Abstract

PURPOSE: Radiotherapy (RT) is a major component of treatment in head and neck malignancies and often the radiation field includes the nasal cavity and olfactory cleft region. We aimed to assess olfaction, mucociliary clearance time and quality of life (QOL) before RT and during the course of radiotherapy.
METHODS: This prospective, observational, cohort study was conducted over a period of 1 year. The olfactory function, mucociliary clearance and QOL of patients with primary head and neck cancers undergoing radiation therapy as part of treatment were assessed prior to radiotherapy and followed up serially up to 3 months after radiotherapy. A total of 21 patients were enrolled. Assessment was done using noninvasive tests for better compliance and ease of examination.
RESULTS: Among the 21 patients recruited, 18 completed radiotherapy and 13 were assessed 3 months post radiotherapy. Mean olfactory scores (including olfactory threshold and odor identification), using Connecticut Chemosensory Clinical Research Center (CCCRC) test, deteriorated significantly at the end of radiotherapy (p < 0.001) as compared to scores before irradiation. Subjective assessment of olfaction by Appetite, Hunger and Sensory perception (AHSP) questionnaire did not demonstrate significant impairment in nasal function (p < 0.319) although overall QOL significantly deteriorated (p 0.004). The mucociliary clearance time was prolonged in 72% of the patients at the end of radiotherapy.
CONCLUSION: Deterioration in olfactory function was found to occur during the course of radiotherapy with gradual improvement after 3 months. However, patients did not notice olfactory dysfunction subjectively. Mucociliary dysfunction persisted even after 3 months following radiation.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mucociliary clearance; Olfaction; Quality of life; Radiotherapy; Smell

Year:  2020        PMID: 32416968     DOI: 10.1016/j.amjoto.2020.102537

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  5 in total

1.  The Impact of Age and Gender and Their Association with Chemosensory Dysfunction, in Hospitalized and Self-Quarantine Patients with Covid-19 Infection, in Epirus, Greece.

Authors:  Athina Zarachi; Vasileios Pezoulas; Orestis Milionis; Aikaterini N Lianou; Eleutherios Klouras; Ioannis Komnos; Dimitrios Fotiadis; Ioannis Kastanioudakis; Charalampos Milionis; Angelos Liontos
Journal:  Maedica (Bucur)       Date:  2022-03

2.  Clinical Symptoms in Hospitalized and Self-Quarantined Patients with SARS-CoV-2 Infection in Northwestern Greece - Association with Olfactory and Gustatory Dysfunction.

Authors:  Athina Zarachi; Vasileios Pezoulas; Ioannis Komnos; Aikaterini Lianou; Orestis Milionis; Eleutherios Klouras; Konstantinos Katsikatsos; Dimitrios Fotiadis; Ioannis Kastanioudakis; Charalampos Milionis; Angelos Liontos
Journal:  Maedica (Bucur)       Date:  2022-06

3.  Moderate Dose Irradiation Induces DNA Damage and Impairments of Barrier and Host Defense in Nasal Epithelial Cells in vitro.

Authors:  Yue-Ying Yang; Jing Liu; Yi-Tong Liu; Hsiao-Hui Ong; Qian-Min Chen; Ce-Belle Chen; Mark Thong; Xinni Xu; Sui-Zi Zhou; Qian-Hui Qiu; De-Yun Wang
Journal:  J Inflamm Res       Date:  2022-06-25

Review 4.  Sinonasal Side Effects of Chemotherapy and/or Radiation Therapy for Head and Neck Cancer: A Literature Review.

Authors:  Giuseppe Riva; Ester Cravero; Claudia Pizzo; Marco Briguglio; Giuseppe Carlo Iorio; Chiara Cavallin; Oliviero Ostellino; Mario Airoldi; Umberto Ricardi; Giancarlo Pecorari
Journal:  Cancers (Basel)       Date:  2022-05-07       Impact factor: 6.575

5.  Potential Mechanisms for COVID-19 Induced Anosmia and Dysgeusia.

Authors:  Adrien A Eshraghi; Mehdi Mirsaeidi; Camron Davies; Fred F Telischi; Nirupa Chaudhari; Rahul Mittal
Journal:  Front Physiol       Date:  2020-09-16       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.